REFERENCES
- CDC. Cigarette smoking among adults in the United States, MMWR (Morb Mortal Wkly). 2002;51:300–303.
- Lasser K, Boyd JW, Woolhander S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. J AMA. 2000;284:2606–2610.
- Degenhardt L, Hall W. The relationship between tobacco use, substance-use disorders and mental health: results from the National Survey of Mental Health and Well-being. Nicotine Tob Res. 2001;3:225–234. [PUBMED], [INFOTRIEVE], [CSA]
- George TP, Vessicchio JC. Nicotine addiction and schizophrenia. Psychiatric Times. 2001;18((2)):39–42.
- Hurt RD, Offord KP, Croghan IT, , et al. Mortality following inpatient addictions treatment: role of tobacco use in a community-based cohort. JAMA. 1996;275:1097–1103. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lichtermann D, Ekelund E, Pukkala E, Tanskanen A, Lonnqvist J. Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry. 2001;58:573–578. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tsuang MT, Perkins K, Simpson JC. Physical diseases in schizophrenia and affective disorder. J Clin Psychiatry. 1983;44:42–46. [PUBMED], [INFOTRIEVE]
- Tsuang MT, Woolson RF, Fleming JA. Premature deaths in schizophrenia and affective disorders: an analysis of survival curves and variables affecting the shortened survival. Arch Gen Psychiatry. 1980;37:979–983. [PUBMED], [INFOTRIEVE]
- Dalack GW, Healy DJ, Meador-Woodruff JH. Nicotine dependence and schizophrenia: clinical phenomenon and laboratory findings. Am J Psychiatry. 1998;155:1490–1501. [PUBMED], [INFOTRIEVE]
- Hughes JR, Hatsukami DK, Mitchell JE, Dahlgreen LA. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry. 1986;143:993–997. [PUBMED], [INFOTRIEVE]
- Glassman AH. Cigarette smoking: implications for psychiatric illness. Am J Psychiatry. 1993;150:546–553. [PUBMED], [INFOTRIEVE]
- Sacco KA, Bannon KL, George TP. Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J Psychopharmacol. 2004;18:457–474. [PUBMED], [INFOTRIEVE], [CROSSREF]
- George TP, Krystal JH. Comorbidity of psychiatric and substance abuse disorders. Curr Opin Psychiatry. 2000;13:327–331. [CROSSREF]
- George TP, O'Malley SS. Current pharmacological treatments for nicotine dependence. Trends Pharmacol Sci. 2004;25:42–48. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Clarke PBS, Fu DS, Jakubovic A, Fibiger HC. Evidence that mesolimbic dopamine activation underlies the locomotor stimulant action of nicotine in rats. J Pharmacol Exp Ther. 1988;246:701–708. [PUBMED], [INFOTRIEVE], [CSA]
- Picciotto MR. Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol Sci. 2003;23:494–499.
- Corrigall WA, Coen KM. Nicotine maintains robust self-administration in rats on a limited access schedule. Psychopharmacology. 1989;99:473–478. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Corrigall WA, Franklin KB, Coen KM, Clarke PB. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology. 1992;107:285–289. [PUBMED], [INFOTRIEVE]
- Fung YK, Schmid MJ, Anderson TM, Lau Y-S. Effects of nicotine withdrawal on central dopaminergic systems. Pharmacol Biochem Behav. 1996;53:635–640. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- George TP, Verrico CD, Roth RH. Effects of repeated nicotine pre-treatment on mesoprefontal dopaminergic and behavioral responses to acute footshock stress. Brain Res. 1998;801:36–49. [PUBMED], [INFOTRIEVE], [CROSSREF]
- West RJ, Russell MAH, Jarvis MJ, Pizzey T, Kadam B. Urinary adrenaline concentrations during 10 days of smoking abstinence. Psychopharmacology. 1984;84:141–142. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ward KD, Garvey AJ, Bliss RE, Sparrow D, Young JB, Landsberg L. Changes in urinary catecholamine excretion after smoking cessation. Pharmacol Biochem Behav. 1991;40:937–940. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kendler KS, Neale MC, MacLean CJ, Heath AC, Eaves LJ, Kessler RC. Smoking and major depression: a causal analysis. Arch Gen Psychiatry. 1993;50:36–43. [PUBMED], [INFOTRIEVE]
- Swan GE, Carmelli D, Cardon LR. The consumption of tobacco, alcohol, and coffee in Caucasian male twins: a multivariate genetic analysis. J Subst Abuse. 1996;8:19–31. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Comings DE, Gade R, Wu S, , et al. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol Psychiatry. 1997;2:44–56. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Comings DE, Ferry L, Bradshaw-Robinson S, Burchette R, Chui C, Muhleman D. The dopamine D2 receptor (DRD2) gene: a genetic risk factor for smoking. Pharmacogenetics. 1996;6:73–79. [PUBMED], [INFOTRIEVE], [CSA]
- Noble EP, St. Jeor ST, Ritchie T, , et al. D2 dopamine receptor gene and cigarette smoking: a reward gene? Med Hypotheses. 1994;42:257–260. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lerman C, Caporaso N, Main D, , et al. Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene. Health Psychol. 1998;17:56–62. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lerman C, Caporaso NE, Audrain J, , et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol. 1999;18:14–20. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Freedman R, Coon H, Myles-Worsley M, , et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Nat Acad Sci USA. 1997;94:587–592. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pianezza ML, Sellers EM, Tyndale RF. Nicotine metabolism defect reduces smoking. Nature. 1998;393:750. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rao Y, Hoffman E, Zia M, , et al. Duplications and defects in the CYP 2A6 gene: identification, genotyping and in vivo effects on smoking. Mol Pharmacol. 2000;58:747–755. [PUBMED], [INFOTRIEVE], [CSA]
- Lerman C, Roth D, Kaufmann V, , et al. Mediating mechanisms for the impact of bupropion in smoking cessation treatment. Drug Alcohol Depend. 2002;69:219–223. [CROSSREF]
- Lerman C, Shields PG, Wileyto EP, , et al. Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics. 2002;12:627–634. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hughes JR, Howard TS. Nicotine and caffeine use as confounds in psychiatric studies. Biol Psychiatry. 1997;42:1184–1185. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ziedonis DM, George TP. Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophr Bull. 1997;23:247–254. [PUBMED], [INFOTRIEVE], [CSA]
- McChargue DE, Gulliver SB, Hitsman B. Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment? Addiction. 2002;97:785–793. [PUBMED], [INFOTRIEVE], [CROSSREF]
- de Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am J Psychiatry. 1995;152:453–455. [PUBMED], [INFOTRIEVE]
- el-Guebaly N, Hodgins D. Schizophrenia and substance abuse: prevalence issues. Can J Psychiatry. 1992;37:704–710. [PUBMED], [INFOTRIEVE], [CSA]
- Masterson E, O'Shea B. Smoking and malignancy in schizophrenia. Brit J Psychiatry. 1984;145:429–432.
- O'Farrell TJ, Connors GJ, Upper D. Addictive behaviors among hospitalized psychiatric patients. Addict Behav. 1983;8:329–333. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Goff DC, Henderson DC, Amico E. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am J Psychiatry. 1992;149:1189–1194. [PUBMED], [INFOTRIEVE]
- George TP, Sernyak MJ, Ziedonis DM, Woods SW. Effects of clozapine on smoking in chronic schizophrenic outpatients. J Clin Psychiatry. 1995;56:344–346. [PUBMED], [INFOTRIEVE]
- Menza MA, Grossman M, Van Horn M, Cody R, Forman N. Smoking and movement disorders in psychiatric patients. Biol Psychiatry. 1991;30:109–115. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Diwan A, Castine M, Pomerleau CS, Meador-Woodruff JH, Dalack GW. Differential prevalence of cigarette smoking in patients with schizophrenia vs. mood disorders. Schizophr Res. 1998;33:113–118. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chong SA, Choo HL. Smoking among Chinese patients with schizophrenia. Aust N Z J Psychiatry. 1996;30:350–353. [PUBMED], [INFOTRIEVE], [CSA]
- Kelly C, McCredie RG. Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am J Psychiatry. 1999;156:1751–1757. [PUBMED], [INFOTRIEVE]
- McEvoy JP, Brown S. Smoking in first-episode patients with schizophrenia. Am J Psychiatry. 1999;156:1120–1121. [PUBMED], [INFOTRIEVE]
- Ziedonis DM, Kosten TR, Glazer WM, Frances RJ. Nicotine dependence and schizophrenia. Hosp Community Psychiatry. 1994;45:204–206. [PUBMED], [INFOTRIEVE], [CSA]
- George TP, Vessicchio JC, Termine A, , et al. A placebo-controlled study of bupropion for smoking cessation in schizophrenia. Biol Psychiatry. 2002;52:53–61. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- George TP, Zeidonis DM, Feingold A, , et al. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry. 2000;157:1835–1842. [PUBMED], [INFOTRIEVE]
- Evins AE, Mays VK, Rigotti NA, Tisdale T, Cather C, Goff DC. A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine Tob Res. 2001;3:397–403. [PUBMED], [INFOTRIEVE], [CSA]
- Hall RG, Duhamel M, McClanahan R, , et al. Level of functioning, severity of illness, and smoking status among chronic psychiatric patients. J Nerv Men Dis. 1995;183:468–471. [CSA]
- Dalack GW, Becks L, Hill E, Pomerleau OF, Meador-Woodruff JH. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia. Neuropsychopharmacology. 1999;21:195–202. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sacco KA, Termine A, Seyal AA ., et al. Effects of cigarette smoking function on spatial working memory and attentional function in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry. 2005, in press.
- Addington J, el-Guebaly N, Campbell W, Hodgins DC, Addington D. Smoking cessation treatment for patients with schizophrenia. Am J Psychiatry. 1998;155:974–976. [PUBMED], [INFOTRIEVE]
- Adler LE, Hoffer LD, Wiser A, Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry. 1993;150:1856–1861. [PUBMED], [INFOTRIEVE]
- Freedman R, Adler LE, Bickford P, , et al. Schizophrenia and nicotinic receptors. Harv Rev Psychiatry. 1994;2:179–192. [PUBMED], [INFOTRIEVE], [CSA]
- Olincy A, Ross RG, Young DA, Roath M, Freedman R. Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients. Neuropsychopharmacology. 1998;18:175–185. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Olincy A, Johnson LL, Ross RG. Differential effects of cigarette smoking on performance of a smooth pursuit and a saccadic eye movement task in schizophrenia. Psychiatry Res. 2003;117:223–236. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Avila MT, Sherr JD, Hong E, Myers CS, Thaker GK. Effects of nicotine on leading saccades during smooth pursuit eye movements in smokers and nonsmokers with schizophrenia. Neuropsychopharmacology. 2003;28:2184–2191. [PUBMED], [INFOTRIEVE], [CSA]
- Leonard S, Gault J, Hopkins J, , et al. Promoter variants in the alpha-7 nicotinic acetylcholine receptor subunit gene are associated with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry. 2002;59:1085–1096. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- George TP, Vessicchio JC, Termine A, , et al. Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology. 2002;26:75–85. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jacobsen LK, D'Souza DC, Mencl WE, Pugh KR, Skudlarski P, Krystal JH. Nicotine effects on brain function and functional connectivity in schizophrenia. Biol Psychiatry. 2004;55:850–858. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Levin ED, Wilson W, Rose J, McEvoy J. Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology. 1996;15:429–436. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Depatie L, Driscoll GA, Holahan A-LV, , et al. Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study. Neuropsychopharmacology. 2002;27:1056–1070. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Decina P, Caracci G, Sandik R, Berman W, Mukerjee S, Scapicchio P. Cigarette smoking and neuroleptic-induced parkinsonism. Biol Psychiatry. 1990;28:502–508. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yassa R, Lal S, Korpassy A, Ally J. Nicotine exposure and tardive dyskinesia. Biol Psychiatry. 1987;30:109–115.
- Yang YK, Nelson L, Kamaraju L, Wilson W, McEvoy JP. Nicotine decreases bradykinesia-rigidity in haloperidol-treated patients with schizophenia. Neuropsychopharmacology. 2002;27:684–686. [PUBMED], [INFOTRIEVE], [CSA]
- Hall SM, Munoz RF, Reus VI, , et al. Nicotine, negative affect and depression. J Consul Clin Psychol. 1993;61:761–767. [CSA], [CROSSREF]
- Matthew RJ, Weinman ML, Mirabi M. Physical symptoms of depression. Br J Psychiatry. 1981;139:293–296.
- Anda RF, Williamson DF, Escobedo LG, , et al. Depression and the dynamics of smoking. JAMA. 1990;264:1541–1545. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Glassman AH, Stetner F, Walsh BT, , et al. Heavy smokers, smoking cessation, and clonidine. JAMA. 1988;259:2863–2866. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Perez-Stable EJ, Marin G, Marin BV, Katz MH. Depressive symptoms and cigarette smoking among Latinos in San Francisco. Am J Public Health. 1990;80:1500–1502. [PUBMED], [INFOTRIEVE], [CSA]
- Niaura R, Britt DM, Shadel WM, Goldstein M, Abrams D, Brown R. Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav. 2001;15:13–17. [PUBMED], [INFOTRIEVE], [CSA]
- Glassman AH, Helzer JE, Covey LS, , et al. Smoking, smoking cessation and major depression. JAMA. 1990;264:1546–1549. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Glassman AH, Covey LS, Dalack GW, , et al. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin Pharmacol Ther. 1993;54:670–679. [PUBMED], [INFOTRIEVE], [CSA]
- Covey LS, Glassman AH, Stetner F. Major depression following smoking cessation. Am J Psychiatry. 1997;154:263–265. [PUBMED], [INFOTRIEVE]
- Thorsteinsson HS, Gillin JC, Patten CA, , et al. The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression. Neuropsychopharmacology. 2001;24:350–358. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tsoh JY, Humfleet GL, Munoz RF, Reus VI, Hartz DT, Hall SM. Development of major depression after treatment for smoking cessation. Am J Psychiatry. 2000;157:368–374. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Breslau N, Kilbey MM, Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. Am J Psychiatry. 1992;149:464–469. [PUBMED], [INFOTRIEVE]
- Gonzalez-Pinto A, Gutierrez M, Ezcurra J, , et al. Tobacco smoking and bipolar disorder. J Clin Psychiatry. 1998;59:225–228. [PUBMED], [INFOTRIEVE]
- Cassidy F, McEvoy JP, Yang Y-K, Wilson WH. Smoking and psychosis in patients with bipolar I disorder. Compr Psychiatry. 2002;43:63–64. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Corvin A, O'Mahoney E, O'Regan M, , et al. Cigarette smoking and psychotic symptoms in bipolar affective disorder. Brit J Psychiatry. 2001;179:35–38. [CROSSREF]
- Baker-Morissette SL, Gulliver SB, Wiegel M, Barlow DH. Prevalence of smoking in anxiety disorders uncomplicated by comorbid alcohol or substance abuse. J Psychopathol Behav Assess. 2004;26:107–112. [CROSSREF]
- Amering M, Bankier B, Berger P, Griengl H, Windhaber J, Katsching H. Panic disorder and cigarette smoking behavior. Compr Psychiatry. 1999;40:35–38. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pohl R, Yergani VK, Balon R, Lycaki H, McBride R. Smoking in patients with panic disorder. Psychiatry Res. 1992;43:253–262. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Himle J, Thyer BA, Fischer DJ. Prevalence of smoking among anxious outpatients. Phobia Pract Res J. 1988;1:25–31.
- Breslau N, Klein DF. Smoking and panic attacks: an epidemiologic investigation. Arch Gen Psychiatry. 1999;56:1141–1147. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Johnson JG, Cohen P, Pine DS, Klein DF, Kasen S, Brook JS. Association between cigarette smoking and anxiety disorders during adolescence and early adulthood. JAMA. 2000;284:2348–2351. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Isensee B, Wittchen H, Stein MB, Hofler M, Lieb R. Smoking increases the risk of panic: findings from a prospective community sample. Arch Gen Psychiatry. 2003;60:692–700. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bejerot S, Humble M. Low prevalence of smoking among patients with obsessive-compulsive disorder. Compl Psychiatry. 1999;40:268–272. [CSA], [CROSSREF]
- McCabe RE, Chudzik SM, Antony MM. Smoking behaviors across anxiety disorders. J Anxiety Disord. 2004;18:7–18. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Beckham JC, Roodman AA, Shipley RH, , et al. Smoking in Vietnam combat veterans with posttraumatic stress disorder. J Trauma Stress. 1995;8:461–472. [PUBMED], [INFOTRIEVE], [CSA]
- Beckham JC, Kirby AC, Feldman ME, , et al. Prevalence and correlates of heavy smoking in Vietnam veterans with chronic posttraumatic stress disorder. Addict Behav. 1997;22:637–647. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Op den Velde W, Aarts PGH, Falger PRJ, , et al. Alcohol use, cigarette consumption and chronic post-traumatic stress disorder. Alcohol Alcohol. 2002;37:355–361. [PUBMED], [INFOTRIEVE]
- Stellman JM, Stellman SD, Sommer JF. Social and behavioral consequences of the Vietnam experience among American Legionnaires. Environ Res. 1988;47:129–149. [PUBMED], [INFOTRIEVE]
- Beckham JC, Lytle BL, Vrana SR, Hertzberg MA, Feldman ME, Shipley RH. Smoking withdrawal symptoms in response to trauma-related stimuli among Vietnam combat veterans with posttraumatic stress. Addic Behav. 1995;20:1–9. [CSA], [CROSSREF]
- Acierno RA, Kilpatrick DG, Resnick HS, Saunders BE, Best CL. Violent assault, posttraumatic stress disorder, and depression: risk factors for cigarette use among adult women. Behavior Modification. 1996;20:363–384. [PUBMED], [INFOTRIEVE], [CSA]
- Vlahov D, Galea S, Resnick H, , et al. Increased use of cigarettes, alcohol and marijuana among Manhattan, New York residents after the September 11th terrorist attacks. Am J Pub Health. 2002;155:988–996.
- Anda RF, Croft JB, Felitti VJ, , et al. Adverse childhood experiences and smoking during adolescence and adulthood. JAMA. 1999;282:1652–1658. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Breslau N, Davis GC, Schultz LR. Posttraumatic stress disorder and the incidence of nicotine, alcohol, and other drug disorders in persons who have experienced trauma. Arch Gen Psychiatry. 2003;60:289–294. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Milberger S, Biederman J, Faraone SV, Chen L, Jones J. ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1997;36:37–44. [PUBMED], [INFOTRIEVE], [CSA]
- Wilens TE, Biederman J, Spencer TJ, , et al. A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1999;156:1931–1937. [PUBMED], [INFOTRIEVE]
- Gulliver SB, Rohsenow DJ, Colby SM, , et al. Interrelationship of smoking and alcohol dependence, use and urges to use. J Stud Alcohol. 1995;56:202–206. [PUBMED], [INFOTRIEVE]
- Gulliver SB, Kalman D, Rohsenow DJ, Colby SM, Monti PM, Eaton CA. Smoking and drinking among alcoholics in treatment: cross-sectional and longitudinal relationships. J Stud Alcohol. 2000;61:157–163. [PUBMED], [INFOTRIEVE]
- Hughes JR. Clinical implications of the association between smoking and alcoholism. In: Fertig J, Fuller R, eds Alcohol and Tobacco: From Basic Science to Policy. Washington, DC: NIAAA Research Monograph; 1995:171–181.
- Kalman D, Tirch D, Kahler C, Penk W, Monti P, Kaschub C. Preliminary finding from an investigation of high dose nicotine patch therapy for heavy smokers with a past history of alcohol dependence. Psychology of Addictive Behaviors. 2004;18:78–82. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Blomqvist O, Hernandez-Avila CA, Van Kirk J, Rose JE, Kranzler HR. Mecamylamine modifies the pharmacokinetics and reinforcing effects of alcohol. Alcohol Clin Exp Res. 2002;26:326–331. [PUBMED], [INFOTRIEVE], [CSA]
- Soderpalm B, Ericson M, Olausson P, Blomqvist O, Engel JA. Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behav Brain Res. 2000;113:85–96. [CSA], [CROSSREF]
- Le AD, Corrigall WA, Watchus J, Harding J, Juzytsch S, Li T-K. Involvement of nicotinic receptors in alcohol self-administration. Alcoholism: Clin Exp Res. 2000;24:155–163. [CSA]
- Blomqvist O, Ericson M, Johnson DH, Engel JA, Solderpalm B. Voluntary ethanol intake in the rat: effects of nicotinic acetylcholine receptor blockade or subchronic nicotine treatment. J Pharmacol. 1996;314:257–267.
- Mitchell SH, deWit H, Zacny JP. Effects of varying ethanol dose on cigarette consumption in healthy normal volunteers. Behav Pharmacol. 1995;6:356–359.
- Perkins KA, Fonte C, Ashcom J, Broge M, Wilson A. Subjective responses to nicotine in smokers may be associated with responses to caffeine and alcohol. Exp Clin Psychopharmacol. 2001;9:91–100. [CSA], [CROSSREF]
- Cooney JL, Cooney NL, Pilkey DT, Kranzler HK, Onken CA. Effects of nicotine deprivation on urges to drink and smoke in alcoholic smokers. Addiction. 2003;98:913–921. [CROSSREF]
- Rohsenow DJ, Monti PM, Colby SM, , et al. Effects of alcohol cues on smoking urges and topography among alcoholic men. Alcohol Clin Exp Res. 1997;21:101–107. [CSA]
- Budney AJ, Higgins ST, Hughes JR, Bickel WK. Nictotine and caffeine use in cocaine-dependent individuals. J Subst Abuse. 1993;5:117–130. [CSA], [CROSSREF]
- Patkar AA, Lundy A, DeMaria P, Purcell C, Leone FT, Weinstein SP. A comparison of nicotine dependence among cocaine and opiate abusers. 6th Annual Meeting of the Society for Research on Nicotine and Tobacco, February 18–21, 2000, Arlington, VA.
- Roll JM, Higgins ST, Budney AJ, Bickel WK, Badger GJ. A comparison of cocaine-dependent cigarette smokers and non-smokers on demographic, drug use and other characteristics. Drug Alcohol Depend. 1996;40:195–201. [CSA], [CROSSREF]
- Horger BA, Giles MK, Schenk S. Preexposure to amphetamine and nicotine pre-disposes rats to self-administer a low dose of cocaine. Psychopharmacology. 1992;107:271–276.
- Zachariou V, Weathers-Lowin A, Caldarone BJ, George TP, Changeaux J-P, Picciotto MR. Nicotine receptor inactivation can decrease sensitivity to cocaine. Neuropsychopharmacology. 2001;24:576–589. [CSA], [CROSSREF]
- Reid MS, Mickalian JD, Delucchi KL, Hall SM, Berger SP. An acute dose of nicotine enhances cue-induced cocaine craving. Drug Alcohol Depend. 1998;49:95–104. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Reid MS, Mickalian JD, Delucchi KL, Berger SP. A nicotinic antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjects. Neuropsychopharmacology. 1999;20:297–307. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Clemmey P, Brooner R, Chutuape MA, Kidorf M, Stitzer M. Smoking habits and attitudes in a methadone maintenance treatment population. Drug Alcohol Depend. 1997;44:123–132. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Berger H, Schweigler M. Smoking characteristics of methadone patients. JAMA. 1972;222:705. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Meyer TJ, Lin MM, Brown LS, Jr. Nicotine dependence and depression among methadone maintenance patients. J Nat Med Assoc. 1996;88:800–804. [CSA]
- Shoptaw S, Jarvik ME, Ling W, Rawson RA. Contingency management for tobacco smoking in methadone-maintained opiate addicts. Addict Behav. 1996;21:409–412. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Story J, Stark MJ. Treating cigarette smoking in methadone maintenance clients. J Psychoactive Drugs. 1991;23:203–215. [PUBMED], [INFOTRIEVE]
- Conner BT, Stein JA, Longshore D, Stacy AW. Associations between drug abuse treatment and cigarette use: evidence of substance replacement. Exp Clin Psychopharmacol. 1999;7:64–71. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McEvoy J, Freudenreich O, McGee M, VanderZwaag C, Levin E, Rose J. Clozapine decreases smoking in patients with chronic schizophrenia. Biol Psychiatry. 1995;37:550–552. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McEvoy JP, Freudenreich O, Wilson WH. Smoking and therapeutic response to clozapine in patients with schizophrenia. Biol Psychiatry. 1999;46:125–129. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ascher JA, Cole JO, Colin JN, , et al. Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry. 1995;56:395–401. [PUBMED], [INFOTRIEVE]
- Niaura R, Borreli B, Hedeker D, , et al. Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment. J Consult Clin Psychology, 2002;70:887–896. [CSA], [CROSSREF]
- Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992;49:876–880. [PUBMED], [INFOTRIEVE]
- O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry. 1992;49:881–887. [PUBMED], [INFOTRIEVE]
- Krishnan-Sarin S, Meandjiza B, O'Malley SS. Nicotine patch and naltrexone for smoking cessation: a preliminary study. Nicotine Tob Res. 2003;5:851–857. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hall SM, Reus VI, Munoz RF, , et al. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry. 1998;55:683–690. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cornelius JR, Perkins KA, Salloum IM, Thase ME, Moss HB. Fluoxetine vs. placebo to decrease the smoking of depressed alcoholic patients. J Clin Psychopharmacol. 1999;19:183–184. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Covey LS, Glassman AH, Stetner F, Rivelli S. A trial of sertraline for smokers with past major depression. Am J Psychiatry. 2002;159:1731–1737. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Addington J. Group treatment for smoking cessation among persons with schizophrenia. Psychiatri Serv. 1998;49:925–928. [CSA]
- Hall SM, Munoz RF, Reus VI. Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol. 1994;62:141–146. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Patten CA, Martin JE, Myers MG, Calfas KJ, Williams CD. Effectiveness of cognitive-behavioral therapy for smokers with histories of alcohol dependence and depression. J Stud Alcohol. 1998;59:327–335. [PUBMED], [INFOTRIEVE]
- Brown RA, Kahler CW, Niaura R, , et al. Cognitive-behavioral treatment for depression in smoking cessation. J Consult Clin Psychol. 2001;3:471–480.
- Burling TA, Salvio MA, Seidner AL, Ramsey TG. Cigarette smoking in alcohol and cocaine abusers. J Subst Abuse. 1996;8:445–452. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bobo JK, Slade J, Hoffman AL. Nicotine addiction counseling for chemical dependent patients. Psychiatri Serv. 1995;46:945–947. [CSA]
- Campbell BK, Wander N, Stark MJ, Holbert T. Treating cigarette smoking in drug-abusing clients. J Subst Abuse Treatment. 1995;12:89–94. [CSA], [CROSSREF]
- Campbell BK, Krumenacker J, Stark MJ. Smoking cessation for clients in chemical dependence treatment: a demonstration project. J Subst Abuse Treatment. 1998;15:313–318. [CSA], [CROSSREF]
- Schmitz JM, Rhoades H, Grabowski J. Contingent reinforcement for reducing carbon monoxide level in methadone maintained patients. Addict Behav. 1995;20:171–179. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sussman S. Smoking cessation among persons in recovery. Subst Use Misuse. 2002;37:1275–1298. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kalman D. Smoking cessation treatment for substance misusers in early recovery: a review of the literature and recommendations for practice. Subst Use Misuse. 1998;33:2021–2047. [PUBMED], [INFOTRIEVE], [CSA]
- O'Brien CP. Principles of the pharmacotherapy of substance abuse disorders. In: Charney DS, Nestler EJ, Bunney BS, eds. Neurobiology of Mental Illness. New York, NY: Oxford University Press; 1999:627–638.
- Burling TA, Ramsey TG, Seidner AL, Kondo CS. Issues related to smoking cessation among substance abusers. J Subst Abuse Treat. 1997;9:27–40.
- George TP, Seyal AA, Dolan SL, Dudas MM, Termine A, Vessicchio JC. Nicotine addiction and schizophrenia: a clinical approach. Primary Psychiatry. 2002;9:48–53.
- Kalman D, Hayes K, Colby SM, Eaton CA, Rohsenow DJ, Monti PM. Concurrent versus delayed smoking cessation treatment for persons in early alcohol recovery: a pilot study. J Subst Abuse Treatment. 2001;20:233–238. [CSA], [CROSSREF]
- Burling TA, Burling AS, Latini D. A controlled smoking cessation trial for substance-dependent inpatients. J Consult Clin Psychol. 2001;69:295–304. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kalman D, Kahler C, Tirch D, Penk W, Kaschib C, Monti PM. Twelve-week outcomes from an investigation of high dose nicotine patch therapy for heavy smokers with a past history of alcohol dependence. Psychol Addictive Behav. 2004;18:78–82. [CSA], [CROSSREF]
- Joseph A, Willenbring M, Nugent S, Nelson D. Timing of alcohol and smoking cessation study. 9th Annual Meeting of the Society for Research on Nicotine & Tobacco, February 19–22, 2003, New Orleans, LA.
- Ellingstad TP, Sobell LC, Sobell MB, Cleland PA, Agrawal S. Alcohol abusers who want to quit smoking: implications for clinical treatment. Drug Alcohol Depend. 1999;54:259–265. [PUBMED], [INFOTRIEVE], [CSA]
- Hser YI, McCarthy WJ, Anglin MD. Tobacco use as a distal predictor of mortality among long-term narcotic addicts. Prev Medi. 1994;23:61–69.
- Burling TA, Marshall GD, Seidner AL. Smoking cessation for substance abuse inpatients. J Subst Abuse. 1991;3:269–276. [PUBMED], [INFOTRIEVE]
- Evins AE, Cather C, Rigotti NA, , et al. Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction. J Clin Psychiatry. 2004;65:307–311. [PUBMED], [INFOTRIEVE]
- Warner KE, Slade J, Sweanor DT. The emerging market for long-term nicotine maintenance. JAMA. 1997;278:1087–1092. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Allebeck P. Schizophrenia: a life-shortening disease. Schizophr Bull. 1989;15:81–89. [PUBMED], [INFOTRIEVE]
- Bobo JK, Lando HA, Walker RD, McIlvain HE. Predictors of tobacco quit attempts among recovering alcoholics. J Subst Abuse. 1996;8:431–443. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hurt RD, Patten CA. Treatment of tobacco dependence in alcoholics. Recent Dev Alcohol. 2003;16:335–359. [PUBMED], [INFOTRIEVE], [CSA]